MindWalk Holdings (HYFT) Price to FCF (2023 - 2026)
Analysis
MindWalk Holdings (HYFT) Price to FCF (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.56 Bn | 58.38 Bn | 1.37 Bn |
| 4 | Moderna | 57.87 Bn | 52.73 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.20 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.54 Bn | 27.70 Bn | - |
| 9 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn |
| 10 | MindWalk Holdings | 61.22 Mn | 52.95 Mn | 1.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -31.79 |
| Jan 31, 2026 | -25.52 |
| Oct 31, 2025 | -30.97 |
| Jul 31, 2025 | -19.37 |
| Apr 30, 2025 | -26.64 |
| Jan 31, 2025 | -16.31 |
| Oct 31, 2024 | -8.05 |
| Jul 31, 2024 | -18.66 |
| Apr 30, 2024 | -103.00 |
| Jan 31, 2024 | -51.21 |
| Oct 31, 2023 | 278.50 |
| Jul 31, 2023 | -202.06 |
| Apr 30, 2023 | -49.16 |
| Jan 31, 2023 | -67.78 |